Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease
Open Access
- 8 August 2011
- Vol. 16 (8), 6732-6740
- https://doi.org/10.3390/molecules16086732
Abstract
With the accelerated aging of human society Alzheimer’s disease (AD) has become one of the most threatening diseases in the elderly. However, there is no efficient therapeutic agent to combat AD. Berberine is a natural isoquinoline alkaloid that possesses a wide range of pharmacological effects. In the present paper, we review the multiple activities of berberine, including antioxidant, acetylcholinesterase and butyrylcholinesterase inhibitory, monoamine oxidase inhibitory, amyloid-b peptide level-reducing and cholesterol-lowering activities, which suggest that berberine may act as a promising multipotent agent to combat AD.Keywords
This publication has 65 references indexed in Scilit:
- Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?British Journal of Clinical Pharmacology, 2011
- Neuropharmacological and pharmacokinetic properties of berberine: a review of recent researchJournal of Pharmacy and Pharmacology, 2009
- Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberinePhytotherapy Research, 2008
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid BerberineJournal of Clinical Endocrinology & Metabolism, 2008
- Efficacy of berberine in patients with type 2 diabetes mellitusMetabolism, 2008
- Prevalence of Dementia in the United States: The Aging, Demographics, and Memory StudyNeuroepidemiology, 2007
- Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairmentFree Radical Biology & Medicine, 2007
- Alzheimer's diseaseThe Lancet, 2006
- Alzheimer's disease: A tangled issueDrug Discovery Today, 2005
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004